{"schema_version":"secwatch.filing_event.v1","accession":"0000927653-25-000138","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.648482+00:00","generated_at":"2026-05-17T00:30:23.560056+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"McKesson Q2 adjusted EPS $9.86, +39% YoY; revenue record $103.2B; raises FY26 guidance","bullets":["Quarterly revenue $103.2B (+10% YoY); GAAP EPS $8.92 vs $1.87; adjusted EPS $9.86 vs $7.07 (+39%).","Generated $2.2B free cash flow in Q2; cash from operations $2.4B.","Raised FY26 adjusted EPS guidance to $38.35-$38.85 (prev. $38.05-$38.55), indicating 16-18% growth.","CEO Brian Tyler cites strength in oncology/multispecialty and biopharma services as growth drivers.","Record first-half revenue of $201B (+16% YoY); net income $1.89B, up 64%."],"urls":{"canonical":"https://secwatch.observer/filing/0000927653-25-000138","json":"https://secwatch.observer/filing/0000927653-25-000138.json","markdown":"https://secwatch.observer/filing/0000927653-25-000138.md","text":"https://secwatch.observer/filing/0000927653-25-000138.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000092765325000138/0000927653-25-000138-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000092765325000138/mck-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:30:23.560056+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}